Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-25-000037 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 23, 2025 |
| Document Date | Dec 22, 2025 |
| Document | View SEC Filing |
Transactions
3
Total Shares
17,019
Total Value
$15,508.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Dec 22, 2025 | Exercise/Conversion | 5,673 | $0.06 | $340.38 | 5,673 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Dec 22, 2025 | Sale | 5,673 | $2.67 | $15,167.90 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Dec 22, 2025 | Exercise/Conversion | 5,673 | $0.00 | $0.00 | 356,286 | Direct | โ | View Details |